Respa

What Respa does

Respa, operated by Ajay Techma Systems Pvt. Ltd. (founded 1989, India-domiciled private limited company), is a niche management systems consultancy serving mid-size pharmaceutical and life science companies. Its core offering, the RESPA enterprise solution, is a registered trademark since 1994 that natively supports cGMP documentation and USFDA 21 CFR Part 11 compliance for regulatory documentation and supply chain management, a workload that general enterprise platforms require extensive customization to address. The platform is built on an Industry 4.0 technology stack incorporating cloud, AI/ML, IoT, big data analytics, blockchain, robotics, and Manufacturing Execution Systems (MES), with claimed development effort exceeding 500-man years and a knowledge base derived from roughly 40 customer engagements.

The company monetizes primarily through professional services engagements (Digital Strategy Consultancy, Operational Excellence Support, Technology Upgrade Support, On-Demand CIO Services) and likely enterprise software licensing and implementation work. Go-to-market is direct enterprise field sales, evidenced by a Calendly booking link for the founder's 15-minute meetings and a contact form offering four interest categories. Marketing is content-led, anchored by the Center of Excellence Pharma 4.0 YouTube channel (48+ videos), a podcast series, blog content on digital transformation and IoT, and a paid Udemy course on Smart Manufacturing in Pharma targeting pharma professionals.

The company is founder-led (Jayant Joshi, Founder & Managing Director; Umesh Naik, CTO and Director), bootstrapped with no institutional funding or external investors disclosed, and operates with 11-50 employees. Service expansion has been incremental (Cloud Services, Digital Transformation, On-Demand CIO) layered on top of the original pharma regulatory and SCM consultancy, with no disclosed acquisitions, partnerships, geographic expansion, or enterprise-level customer logos.

Name

Respa

Legal name

Ajay Techma Systems Pvt. Ltd.

Website

https://respa.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

Respa, operated by India's Ajay Techma Systems, provides regulatory and supply chain management software and consultancy to mid-size pharmaceutical and life science companies, built on an Industry 4.0 stack covering cGMP, 21 CFR Part 11, MES, cloud, IoT, and AI.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Compliance Software

NAICS

Software Publishers (513210)

SIC

Services-Prepackaged Software (7372)

akta.pro industry

PRIMARYHLAGAOAD

Regulatory Affairs & Submissions FSP

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

SECONDARYHLAGAAAG

Medical Writing & Regulatory Submission Support CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAOAM

Validation, Engineering & Facilities (CSV/Equipment/Utilities) Staffing FSP

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

• Pharmaceutical compliance software
• Regulatory documentation systems
• Life science consulting
• Supply chain management
• Pharma digital transformation

Headquarters

HQ city

Addison

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Management Consultancy Services: Pharma Technologies offers management systems consultancy to the Life Science industry at all stages of the system lifecycle. Services include Digital Strategy Consultancy, Operational Excellence Support, Technology Upgrade Support, and On-Demand CIO services. Revenue is generated through professional services engagements.
2. Education and Training Courses: The company offers the 'Smart Manufacturing in Pharma' course on Udemy, a training program for professionals in the pharmaceutical industry. Revenue generated through course enrollments.
3. Software Licensing and Implementation: RESPA is an existing enterprise solution for regulatory and supply chain management. The company likely generates revenue through software licensing and implementation services for the enterprise solution.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Respa develops and licenses the RESPA enterprise solution, an end-to-end regulatory documentation and supply chain management platform purpose-built for the pharmaceutical and life science vertical. It natively supports cGMP documentation and USFDA 21 CFR Part 11 compliance, and is sold alongside professional services including Digital Strategy Consultancy, On-Demand CIO Services, Cloud Services, and Pharma Technologies consultancy across the full system lifecycle. The company also runs the Center of Excellence Pharma 4.0 content platform and an online Smart Manufacturing in Pharma course as awareness and training offerings.

Product overview

RESPA is an enterprise regulatory and supply chain management (SCM) solution for the Life Science/Pharmaceutical vertical, meeting cGMP documentation requirements and USFDA 21 CFR Part 11 compliance (registered trademark since 1994, developed by Ajay Techma Systems). The portfolio includes the core RESPA product complemented by the Center of Excellence Pharma 4.0 initiative (YouTube channel, podcasts, e-learning platform), plus service offerings: Cloud Services, Digital Transformation Services, On-Demand CIO Services, Pharma Technologies Consultancy Services, and a Smart Manufacturing in Pharma Udemy course. These offerings form a holistic approach to helping pharmaceutical companies achieve regulatory compliance, operational excellence, and digital transformation through emerging technologies.

Differentiator

Problem solved

Functional benefit

Products and services

• RESPA Enterprise Solution End-to-end enterprise regulatory documentation and supply chain management platform purpose-built for pharmaceutical and life science manufacturers, providing native cGMP documentation support and USFDA 21 CFR Part 11 compliance. Sold to pharma and life science companies under software licensing and implementation terms.
• Cloud Services Comprehensive cloud services covering cloud migration, infrastructure setup and management, application development and deployment, cloud security and compliance, and cloud optimization and cost management. Sold as a professional services engagement to organizations undertaking cloud adoption.
• Digital Transformation Services Consultancy engagement covering digital strategy and roadmap, technology evaluation and adoption, IoT solutions and connectivity, big data analytics and insights, and cloud services and migration. Targeted at organizations seeking Industry 4.0 adoption.
• On-Demand CIO Services Flexible and scalable CIO-as-a-service engagement providing strategic technology guidance across IT governance, digital transformation, vendor management, and IT security and compliance. Targeted at mid-size organizations that cannot justify a full-time CIO.
• Pharma Technologies Consultancy Services Management systems consultancy covering MES, SCM, regulatory and operational systems, and digital transformation project lifecycle support for Life Science customers. Delivered by certified, world-class-trained consultants.
• Smart Manufacturing in Pharma (Udemy course) Online training course covering Smart Manufacturing / Pharma 4.0 principles, regulatory landscape, IoT, big data analytics, AI, machine learning, continuous manufacturing, real-time monitoring, data integration, process optimization and predictive maintenance. Sold via per-enrollment pricing on Udemy.

Quantifiable outcome

• Employees spend up to 30% of productive time on documentation - automation can significantly improve productivity
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature3 records

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• Qualio: Qualio provides a cloud quality management system for life sciences manufacturers, covering document control, training, and supplier management aligned with FDA/ISO expectations. It is a niche competitor to RESPA in the compliance software layer.
• Dot Compliance: Dot Compliance offers cloud-based quality and compliance solutions for life sciences on Salesforce, including document management, training, and CAPA. It targets the same mid-size pharma buyer as Respa with a more modern SaaS delivery model.
• Yseop (AI for Pharma regulatory writing): Yseop applies generative AI to automate regulatory and medical writing for pharma, including clinical study reports and submission documents. It is an emerging adjacent player attacking the same regulatory documentation budget that RESPA's product supports.

Direct peers

• Honeywell TrackWise (Sparta Systems): TrackWise is an enterprise quality management system (QMS) widely used by pharma manufacturers for deviation, CAPA, and audit workflows supporting 21 CFR Part 11 compliance. It competes with Respa for the same regulatory and quality management budget line.
• MasterControl: MasterControl provides quality management and regulatory compliance software for life sciences manufacturers, including electronic batch records, document control, and validation tools. It directly overlaps with RESPA's cGMP/21 CFR Part 11 documentation and quality value proposition.
• Veeva Systems: Veeva is a cloud software provider serving the life sciences industry with regulated content, quality, clinical, and regulatory solutions. It is directly comparable to Respa as both target pharma/life science buyers with cloud-based, compliance-oriented platforms and have built vertical SaaS moats.
• Aptean (formerly AX for Pharma / ProcessPro): Aptean offers ERP and process manufacturing software tailored for pharmaceutical and life sciences customers, including batch processing, quality, and regulatory features. It competes head-to-head with Respa's RESPA enterprise solution for mid-market pharma IT spend.

Broad incumbents

• ZS Associates: ZS is a large global management consulting and technology firm dedicated to pharma and life sciences, offering strategy, operations, and digital transformation services. It competes with Respa's consultancy arm for pharma digital transformation engagements.
• Cognizant Life Sciences: Cognizant is a global IT services firm with a dedicated life sciences practice providing digital transformation, MES implementation, and regulatory compliance consulting. It overlaps with Respa's pharma consultancy and digital transformation service lines.
• IQVIA: IQVIA is a global life sciences services and technology leader spanning clinical, commercial, and technology/analytics. Its technology and consulting overlap with Respa's regulatory/SCM consulting and digital transformation offerings for pharma manufacturers.

Market position

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@COE-PHARMA4.0
• LinkedInlinkedin.com/company/respa-inc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Respa